UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Don’t Stop Post–Sustained Virologic Response Hepatocellular Carcinoma Surveillance Just Yet

Clinical infectious diseases, 2020-12, Vol.71 (9), p.2363-2364

2020

Volltextzugriff (PDF)

Hepatitis C: looking into the future

Expert review of gastroenterology & hepatology, 2020-05, Vol.14 (5), p.367-374

Massoud, Omar

2020

Volltextzugriff (PDF)

Hepatitis C virus relapse after successful treatment with direct-acting antivirals, followed by sarcomatous changes in hepatocellular carcinoma: a case report

Journal of medical case reports, 2020-05, Vol.14 (1), p.62-62, Article 62

2020

Volltextzugriff (PDF)

Better executive function is independently associated with full HIV suppression during combination therapy

AIDS (London), 2019-12, Vol.33 (15), p.2309-2316

2019

Volltextzugriff (PDF)

Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation

Journal of hepatology, 2016-07, Vol.65 (1), p.17-25

2016

Volltextzugriff (PDF)

Epigenetic scars in regulatory T cells are retained after successful treatment of chronic hepatitis C with direct-acting antivirals

Journal of hepatology, 2024-06

2024

Volltextzugriff (PDF)

Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension

Journal of hepatology, 2016-10, Vol.65 (4), p.692-699

2016

Volltextzugriff (PDF)

EASL Recommendations on Treatment of Hepatitis C 2016

Journal of hepatology, 2017-01, Vol.66 (1), p.153-194

2017

Volltextzugriff (PDF)

HCC surveillance after SVR in patients with F3/F4 fibrosis

Journal of hepatology, 2021-02, Vol.74 (2), p.458-465

Ioannou, George N.

2021

Volltextzugriff (PDF)

Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges

Gastroenterology (New York, N.Y. 1943), 2019-01, Vol.156 (2), p.431-445

2019

Volltextzugriff (PDF)

Toward hepatitis C virus elimination using artificial intelligence

Clinical and molecular hepatology, 2024-04, Vol.30 (2), p.147

2024

Volltextzugriff (PDF)

Two Cases of Hepatocellular Carcinoma Arising Over 20 years After a Sustained Virologic Response Following Interferon Therapy for Chronic Hepatitis C

Internal Medicine, 2020, pp.4479-20

2020

Volltextzugriff (PDF)

Reversion of disease manifestations after HCV eradication

Journal of hepatology, 2016-10, Vol.65 (1), p.S95-S108

2016

Volltextzugriff (PDF)

Real-world Safety and Effectiveness of 24-week Sofosbuvir and Ribavirin Treatment in Patients Infected with Rare Chronic Hepatitis C Virus Genotypes 3, 4, 5, or 6 in Japan

Internal Medicine, 2022, pp.0067-22

2022

Volltextzugriff (PDF)

Magnitude and Kinetics of Decrease in Liver Stiffness After Antiviral Therapy in Patients With Chronic Hepatitis C: A Systematic Review and Meta-analysis

Clinical gastroenterology and hepatology, 2018-01, Vol.16 (1), p.27-38.e4

2018

Volltextzugriff (PDF)

Surveillance and management of hepatocellular carcinoma after treatment of hepatitis C with direct-acting antiviral drugs

Annals of hepatology, 2024-09, p.101582, Article 101582

2024

Volltextzugriff (PDF)

Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting

The lancet HIV, 2019-04, Vol.6 (4), p.e259-e268

2019

Volltextzugriff (PDF)

Single-Cell Characterization of Viral Translation-Competent Reservoirs in HIV-Infected Individuals

Cell host & microbe, 2016-09, Vol.20 (3), p.368-380

2016

Volltextzugriff (PDF)

Treatment of hepatitis C virus infection with direct‐acting antiviral agents: 100% cure?

Liver international, 2018-02, Vol.38 (S1), p.7-13

2018

Volltextzugriff (PDF)

Hepatitis B cure: From discovery to regulatory approval

Journal of hepatology, 2017-10, Vol.67 (4), p.847-861

2017

Volltextzugriff (PDF)

Real-life experience of ledipasvir and sofosbuvir for HCV infected Korean patients: a multicenter cohort study

The Korean journal of internal medicine, 2022-11, Vol.37 (6), p.1167

2022

Volltextzugriff (PDF)

Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside

Gastroenterology (New York, N.Y. 1943), 2021-04, Vol.160 (5), p.1502-1520.e1

2021

Volltextzugriff (PDF)

1 – 25 von 1.030

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(916)
Mit Volltextzugriff
(875)

Publikationsform

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Sustained Virologic Response
(1.003)
Science & Technology
(833)
Life Sciences & Biomedicine
(822)
Humans
(662)
Hepatitis C
(438)
Antiviral Agents - Therapeutic Use
(407)
Gastroenterology & Hepatology
(402)
Hepatitis C, Chronic - Drug Therapy
(372)
Hepatitis C Virus
(288)
Infectious Diseases
(241)
Antiviral Agents
(212)
Hepatitis
(208)
Treatment Outcome
(195)
Female
(184)
Male
(184)
Hepacivirus - Genetics
(176)
Hepatitis C - Drug Therapy
(174)
Patients
(173)
Genotype
(171)
Interferon
(164)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Don’t Stop Post–Sustained Virologic Response Hepatocellular Carcinoma Surveillance Just Yet

Hepatitis C: looking into the future

Hepatitis C virus relapse after successful treatment with direct-acting antivirals, followed by sarcomatous changes in hepatocellular carcinoma: a case report

Better executive function is independently associated with full HIV suppression during combination therapy

Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation

Epigenetic scars in regulatory T cells are retained after successful treatment of chronic hepatitis C with direct-acting antivirals

Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension

EASL Recommendations on Treatment of Hepatitis C 2016

Non-invasive tests for clinically significant portal hypertension after HCV cure

HCC surveillance after SVR in patients with F3/F4 fibrosis

Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges

Toward hepatitis C virus elimination using artificial intelligence

Two Cases of Hepatocellular Carcinoma Arising Over 20 years After a Sustained Virologic Response Following Interferon Therapy for Chronic Hepatitis C

HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response

Reversion of disease manifestations after HCV eradication

HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease

Real-world Safety and Effectiveness of 24-week Sofosbuvir and Ribavirin Treatment in Patients Infected with Rare Chronic Hepatitis C Virus Genotypes 3, 4, 5, or 6 in Japan

Magnitude and Kinetics of Decrease in Liver Stiffness After Antiviral Therapy in Patients With Chronic Hepatitis C: A Systematic Review and Meta-analysis

Surveillance and management of hepatocellular carcinoma after treatment of hepatitis C with direct-acting antiviral drugs

Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting

Single-Cell Characterization of Viral Translation-Competent Reservoirs in HIV-Infected Individuals

Treatment of hepatitis C virus infection with direct‐acting antiviral agents: 100% cure?

Hepatitis B cure: From discovery to regulatory approval

Real-life experience of ledipasvir and sofosbuvir for HCV infected Korean patients: a multicenter cohort study

Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside

Aktive Filter

Suchergebnisse filtern